180 results
8-K
EX-10.3
THER
Theralink Technologies, Inc.
3 Nov 10
Entry into a Material Definitive Agreement
12:00am
States in respect of any of the Securities which would include any activities undertaken for the purpose of, or that could reasonably be expected to have … States in respect of any of the Securities which would include any activities undertaken for the purpose of, or that could reasonably be expected
8-K
EX-10.2
THER
Theralink Technologies, Inc.
2 Dec 10
Entry into a Material Definitive Agreement
12:00am
in respect of any of the Securities which would include any activities undertaken for the purpose of, or that could reasonably be expected to have the effect
8-K
EX-3.1
THER
Theralink Technologies, Inc.
1 Nov 13
QUINT Engages Lexicon for Entertainment Public Relations
12:00am
. The attendance of a director at a meeting constitutes a waiver of notice of such meeting, unless the express purpose of a director’s attendance is to protest … the greater of (a) $100,000or (b) 2% of the annual budget, in the aggregate,from the annual budget will be deemed to be a material change for the purpose
8-K
EX-4.2
THER
Theralink Technologies, Inc.
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior … record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend
8-K
EX-10.2
a979c404811lika yle
28 Sep 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.1
z3mkju
3 Nov 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.1
nvq b6kazy
6 Aug 21
Entry into a Material Definitive Agreement
4:50pm
8-K
EX-4.2
nhrv z5deylc
5 Nov 21
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-4.3
o9w4pzi04
3 Feb 22
Entry into a Material Definitive Agreement
5:11pm
8-K
EX-10.1
phll7xqz94c
22 Feb 11
Departure of Directors or Certain Officers
12:00am
8-K
EX-4.2
1ul8fgisr zqboa
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm
8-K
EX-4.2
xepvgu6x axe
19 May 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
j30exf2d
20 Apr 21
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.1
zdu rxhc2qgx4pv
11 May 11
Entry into a Material Definitive Agreement
12:00am
8-K/A
EX-10.2
izoxt
21 Feb 19
Financial Statements and Exhibits
5:14pm
8-K
EX-10.1
vqwnfw v4
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm
PRE 14C
n7z9g2vh1nkzalg93
22 Feb 19
Preliminary information
5:27pm
8-K
EX-10.1
xsirzx o5oj
29 Jul 10
First Acquisition for Specialty Pharmaceutical Company
12:00am